Disease-Modifying Therapy, Quantitative Imaging, and AI for Managing Patients with Alzheimer Disease
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Disease-Modifying Therapy, Quantitative Imaging, and AI for Managing Patients with Alzheimer Disease
-
Narrated by:
-
By:
About this listen
In this discussion, Dr Tanenbaum and Suzie Bash, MD, a Medical Director at RadNet in Los Angeles, cover the intersection of disease-modifying therapies (DMTs), quantitative imaging, and artificial intelligence (AI) in managing Alzheimer disease.
What listeners say about Disease-Modifying Therapy, Quantitative Imaging, and AI for Managing Patients with Alzheimer Disease
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.